Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study.
D000328:Adult; D000375:Aging; D000906:Antibodies; D000918:Antibody Specificity; D001797:Blood Protein Electrophoresis; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000209:etiology / Q000276:immunology*; D003168:Complement Fixation Tests; D005260:Female; D005326:Fetal Proteins / Q000378:metabolism; D006386:Hemagglutination Tests; D006509:Hepatitis B / Q000097:blood / Q000150:complications; D006511:Hepatitis B Antigens; D006515:Hepatitis B virus / Q000378:metabolism*; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D008103:Liver Cirrhosis / Q000097:blood / Q000276:immunology; D008113:Liver Neoplasms; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D014454:Uganda
D000906:Antibodies; D005326:Fetal Proteins; D006511:Hepatitis B Antigens; D007106:Immune Sera